
Dirank MF 1mg/500mg Tablet SR
Marketer
Frank Medilink
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Dirank MF 1mg/500mg Tablet SR
Diabexe Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined individually by your physician and may be adjusted based on your blood sugar readings. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, characterized by symptoms like sweating, lightheadedness, headache, and tremors. Prompt glucose intake (sugary foods or juice) is essential; carry a fast-acting source at all times. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, will be necessary.
Primary Ingredients of Dirank MF 1mg/500mg Tablet SR
The provided text is "undefined," so no rephrasing is possible.
Uses of Dirank MF 1mg/500mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Dirank MF 1mg/500mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Dirank MF 1mg/500mg Extended-Release Tablets should be taken with food.
Common Side effects of Dirank MF 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Dirank MF 1mg/500mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Dirank MF 1mg/500mg Extended-Release Tablet with food.
How Dirank MF 1mg/500mg Tablet SR works:
Dirank MF 1mg/500mg Extended-Release Tablets combine glimepiride and metformin, two distinct anti-diabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose output, inhibiting intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Dirank MF 1mg/500mg Tablet SR is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Dirank MF 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Extended-release Dirank MF 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Dirank MF 1mg/500mg Tablet SR; dosage modification may be necessary. Severe kidney disease contraindicates the use of Dirank MF 1mg/500mg Tablet SR. Physician consultation is recommended. Regular monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Dirank MF 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Individuals with mild to moderate hepatic dysfunction should begin with a low Dirank MF 1mg/500mg SR tablet dosage; the medication is contraindicated in those with severe liver disease.
What if you forget to take Dirank MF 1mg/500mg Tablet SR :
Should you forget a Dirank MF 1mg/500mg Tablet SR dose, take it immediately if possible. However, near your next scheduled dose, omit the missed dose and resume your normal dosing regimen. Never take a double dose.
Facts to Know About Dirank MF 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
